Whether public and private insurance plans should cover GLP-1 agonists when prescribed primarily for weight loss has been a significant topic of interest and debate. GLP-1 agonists are a class of prescription medications that were developed to help people with … The post Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss appeared first on Peterson-KFF Health System Tracker.
